Rodabe N. Amaria, MD, explains a trial of OBX-115, a novel engineered tumor infiltrating lymphocyte therapy, in checkpoint ...

SYN-2510 shows early clinical promise in solid tumors, with plans for phase 3 trials in NSCLC and breast cancer by mid-to-late 2026. Despite having cash to fund operations until 2026, TIL's ...

U.S. stocks staged a comeback on Friday, with the S&P 500 surging 1.59% and reversing a sharp sell-off driven by fears that Donald Trump’s tariffs ...

Clinical trials offer hope and access to potentially life-saving treatments, especially for the Black community.

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...

Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid malignant tumors.

This Perspective outlines evidence on existing platform trials in mental health and discusses key challenges and strategies to overcome barriers in order to maximize the potential of platform trials.

Black Americans are more willing to participate in medical studies led by Black doctors and researchers, perceiving them as ...

Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a ...